$10.760
+0.010 (+0.09%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de DMAA por análisis de gráficos similares
Alphio's DMAA stock price prediction model matches the current Drugs Made In America Acquisition Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.71 (-0.44%). The 1-week path is $10.38 (-3.50%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Drugs Made In America Acquisition Corp?
Currently, DMAA is not a strong buy due to its high P/E ratio of 55.63 and a low current ratio of 0.02, indicating potential liquidity issues. The RSI is at 61.24, suggesting it is nearing overbought territory, which may limit upside potential in the short term.
DMAA cerró en $10.76 el Tuesday, tras subir +0.09%
Drugs Made In America Acquisition Corp (DMAA) last closed at $10.755, gaining +0.05%. These facts feed the 1-day and 1-week DMAA price prediction above.
Factores de la previsión
Los factores de la previsión de Drugs Made In America Acquisition Corp (DMAA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de DMAA, ordenadas por similitud.
Análisis de estacionalidad de DMAA
Historically the probability of a positive September return for DMAA is 100.00%. April offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de DMAA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $6.97 | $9.13 | $10.59 | -15.11% |
| Oct 2026 | $9.44 | $10.44 | $11.98 | -2.91% |
| Nov 2026 | $9.61 | $11.80 | $13.16 | +9.71% |
| Dec 2026 | $9.57 | $9.82 | $10.91 | -8.68% |
En 2026, se proyecta que Drugs Made In America Acquisition Corp (DMAA) oscile entre $6.97 y $13.16.
Previsión mensual de Drugs Made In America Acquisition Corp para 2026
En Sep de 2026, se proyecta que Drugs Made In America Acquisition Corp promedie $9.13, con un mínimo de $6.97 y un máximo de $10.59.
En Oct de 2026, se proyecta que Drugs Made In America Acquisition Corp promedie $10.44, con un mínimo de $9.44 y un máximo de $11.98.
En Nov de 2026, se proyecta que Drugs Made In America Acquisition Corp promedie $11.80, con un mínimo de $9.61 y un máximo de $13.16.
En Dec de 2026, se proyecta que Drugs Made In America Acquisition Corp promedie $9.82, con un mínimo de $9.57 y un máximo de $10.91.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.